Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2021 Earnings Conference Call March 23, 2022 8:30 AM ET Company Participants Robert Borchert - SVP, Investor and Corporate Communications Shawn Morris - CEO David Mountcastle - CFO Parth Mehrotra - President and COO Conference Call Participants Josh Raskin - Nephron Research Whit Mayo - SVB Leerink Jailendra Singh - Credit Suisse Lisa Gill - JPMorgan Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity Nick Spiekhout - William Blair Operator Good ...

SPRIVIA 1 H E A L T H 4 th Quarter & Full Year 2021 Results March 23, 2022 Shawn Morris – Chief Executive Officer Parth Mehrotra – President & COO David Mountcastle – Chief Financial Officer Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2022 financial guidance and other projectio ...

| --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Empowering Physicians | | | | | | | | TRANSFORMING | | | | | | | | J.P. Morgan Healthcare Conference January 10, 2022 HEALTHCARE | | | | | | | | | | | | | | | | | | | | | | | Disclaimer Forward-Looking Statements This presen ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Gr ...

| --- | --- | --- | --- | --- | --- | --- | |----------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Third Quarter 2021 Results | | | | | | | Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not ...

Privia Health Group, Inc. (NASDAQ:PRVA) Q3 2021 Earnings Conference Call November 8, 2021 8:00 AM ET Company Participants Robert Borchert - Senior Vice President of Investor and Corporate Communications Shawn Morris - Chief Executive Officer Parth Mehrotra - President and Chief Operating Officer David Mountcastle - Chief Financial Officer Conference Call Participants Jailendra Singh - Credit Suisse Ryan Daniels - William Blair Joshua Raskin - Nephron Research Lisa Gill - JPMorgan Richard Close - Canacco ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, ...

Financial Data and Key Metrics Changes - Practice collections increased by 30.3% to over $367 million compared to the second quarter of the previous year [11] - Care margin grew by 33.7% year-over-year, indicating strong financial performance [24] - Adjusted EBITDA rose by 43% in the quarter, with adjusted EBITDA margin expanding by 110 basis points year-over-year [25] Business Line Data and Key Metrics Changes - The company reported a 30.3% increase in practice collections driven by growth in implemented providers and attributed lives [23] - Year-to-date performance showed practice collections up nearly 17% and care margin increasing approximately 21% compared to the first half of 2020 [26] Market Data and Key Metrics Changes - Medicare Advantage lives increased by 13% sequentially to 102,000 at the end of the second quarter [20] - The company currently participates in over 70 at-risk value-based care programs across various payer contracts [18] Company Strategy and Development Direction - The launch of Privia Care Partners aims to expand partnerships with providers without requiring them to switch to a single tax ID medical group [14][15] - The company plans to grow attributed lives and transition more of these lives into downside and full risk arrangements over time [20] - The five core strategies for growth include same store growth, increasing attribution and risk-based contracts, adding new providers, opening new markets, and pursuing M&A opportunities [28] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the significant opportunities in expanding risk-sharing arrangements across value-based reimbursement models [17] - The company expects attributed lives, practice collections, GAAP revenue, care margin, platform contribution, and adjusted EBITDA to be near the high end of guidance ranges for the remainder of 2021 [27] Other Important Information - The company has a net cash position of $266 million, providing sufficient capital for growth initiatives [25] - The management team has decades of experience in managing and underwriting risk, which positions the company well for future transitions in value-based care [21] Q&A Session Summary Question: Can you offer more detail around Privia Care Partners? - The model is designed for value-based care and includes MSO services, allowing providers to participate without switching platforms [34] Question: How does the utilization trend impact Privia? - The company is seeing positive impacts from both fee-for-service and value-based sides, demonstrating resilience across different utilization scenarios [39] Question: What is the provider pipeline outlook for 2022? - The company has a consistent sales approach throughout the year, with a strong pipeline for implementation in 2022 already under contract [42] Question: How do the economics of Privia Care Partners compare to traditional models? - The economics are expected to be similar, with a focus on attributed lives and participation in various value-based programs [45] Question: What is the competitive landscape for the new model? - The lighter model is not a direct reaction to market pressures but a strategic expansion to engage providers who are not ready for a full switch [64]

| --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2021 financial guidance and other projections and forecasts. These f ...

Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2021 Earnings Conference Call May 27, 2021 5:00 PM ET Company Participants Robert Borchert - Senior Vice President of Investor & Corporate Communications Shawn Morris - Chief Executive Officer Parth Mehrotra - President & Chief Operating Officer Conference Call Participants Lisa Gill - JP Morgan Jailendra Singh - Credit Suisse Sandy Draper - Truist Securities Ryan Daniels - William Blair Josh Raskin - Nephron Research Richard Close - Canaccord Genuity Jessica Tassa ...